From: MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up
VB
6M
12M
18M
24M
HHV-6 DNA prevalence in serum
28 / 154
22 / 154
19 / 154
18 / 154
16 / 154
18.2%
14.3%
12.3%
11.7%
10.4%
p (between the basal visit and the 24-month visit)
0.050
OR (between the basal visit and the 24-month visit)
1.92 (0.95-3.91)